Rifampin 300 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DR26FV6C1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,302
Award facts
- Contract value 100% obligated
- $6,301.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,301.95 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency operations and other government healthcare systems. The company's contract performance demonstrates versatility in fulfilling diverse federal medical procurement requirements, ranging from small-value transactions to substantial orders. Rifampin, an antibiotic used primarily in the treatment of tuberculosis and certain infections, represents one of many pharmaceutical products the company delivers through its DLA contracts. The competitive award reflects AmerisourceBergen's established capability to meet federal procurement requirements and support military healthcare needs through open competition.
Quick answers
Who was awarded contract SPE2DR26FV6C1?
SPE2DR26FV6C1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FV6C1 worth?
The government has obligated $6,302 on SPE2DR26FV6C1.
Is contract SPE2DR26FV6C1 an order under another contract?
Yes. SPE2DR26FV6C1 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6C1 competed?
The extent of competition for SPE2DR26FV6C1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award